Moreover, we first demonstrate that METTL3 promotes CRC metastasis by accelerating pri-miR-196b maturation in an m6A-dependent manner; this finding may provide a potential therapeutic target for antimetastatic strategies against CRC. Here, METTL3 is linked to colorectal carcinoma.